Glasziou, Paul; Haas, Marion - Centre for Health Economics Research & Evaluation … - 1994
This analysis compared the costs and benefits of tamoxifen for women with early breast cancer. The main question addressed was: what are the costs and benefits of the use of tamoxifen as an adjuvant treatment in terms of survival and disease free survival for women? Survival and disease free...